Shinn-Ying Ho
Overview
Explore the profile of Shinn-Ying Ho including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
88
Citations
1493
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ho Y, Ho Y, Ko F, Ho S
Annu Int Conf IEEE Eng Med Biol Soc
. 2025 Mar;
2024:1-5.
PMID: 40039814
In recent years, long non-coding RNAs (lncRNAs) have emerged as potential regulators of biological processes and genes, with the potential to serve as valuable biomarkers for cancer diagnosis and prognosis...
2.
Yerukala Sathipati S, Jeong S, Sharma P, Mayer J, Sharma R, Ho S, et al.
Mol Ther Oncol
. 2024 Oct;
32(4):200874.
PMID: 39399813
Kidney cancer, particularly clear cell renal cell carcinoma (KIRC), presents significant challenges in disease-specific survival. This study investigates the prognostic potential of microRNAs (miRNAs) in kidney cancers, including KIRC and...
3.
Chen T, Ho Y, Ko F, Wu P, Chang C, Ho S
AMB Express
. 2024 Aug;
14(1):95.
PMID: 39215890
T and B cell activation are equally important in triggering and orchestrating adaptive host responses to design multi-epitope African swine fever virus (ASFV) vaccines. However, few design methods have considered...
4.
Lee I, Tsai Y, Lin Y, Chen T, Yen C, Chiu N, et al.
Cancer Imaging
. 2024 Mar;
24(1):43.
PMID: 38532511
Background: Automatic segmentation of hepatocellular carcinoma (HCC) on computed tomography (CT) scans is in urgent need to assist diagnosis and radiomics analysis. The aim of this study is to develop...
5.
Yerukala Sathipati S, Tsai M, Aimalla N, Moat L, Shukla S, Allaire P, et al.
NAR Genom Bioinform
. 2024 Feb;
6(1):lqae022.
PMID: 38406797
Breast cancer (BC) is one of the most commonly diagnosed cancers worldwide. As key regulatory molecules in several biological processes, microRNAs (miRNAs) are potential biomarkers for cancer. Understanding the miRNA...
6.
Chung H, Chen J, Chen H, Ko F, Ho S
BMC Med
. 2024 Feb;
22(1):68.
PMID: 38360711
Background: Follow-up visits for very preterm infants (VPI) after hospital discharge is crucial for their neurodevelopmental trajectories, but ensuring their attendance before 12 months corrected age (CA) remains a challenge....
7.
Yerukala Sathipati S, Aimalla N, Tsai M, Carter T, Jeong S, Wen Z, et al.
Carcinogenesis
. 2023 Sep;
44(8-9):650-661.
PMID: 37701974
Objective: Hepatocellular carcinoma (HCC) is one of the leading cancer types with increasing annual incidence and high mortality in the USA. MicroRNAs (miRNAs) have emerged as valuable prognostic indicators in...
8.
Huang T, Lin Y, Yen C, Lan J, Yu C, Lin W, et al.
Cancer Imaging
. 2023 Sep;
23(1):84.
PMID: 37700385
Background: Extranodal extension (ENE) in head and neck squamous cell carcinoma (HNSCC) correlates to poor prognoses and influences treatment strategies. Deep learning may yield promising performance of predicting ENE in...
9.
Yerukala Sathipati S, Ho S
Heliyon
. 2023 Jun;
9(6):e17218.
PMID: 37360084
Head and neck carcinoma (HNSC) is often diagnosed at advanced stage, incurring poor patient outcome. Despite of advances in chemoradiation and surgery approaches, limited improvements in survival rates of HNSC...
10.
Yerukala Sathipati S, Tsai M, Shukla S, Ho S
HGG Adv
. 2023 May;
4(3):100190.
PMID: 37124139
The ability to detect cancer at an early stage in patients who would benefit from effective therapy is a key factor in increasing survivability. This work proposes an evolutionary supervised...